BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 24989615)

  • 21. Estimating a constant WTP for a QALY-a mission impossible?
    Sund B; Svensson M
    Eur J Health Econ; 2018 Jul; 19(6):871-880. PubMed ID: 28932914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimation of the value of curative therapies in oncology: a willingness-to-pay study in China.
    Huang L; Peng X; Sun L; Zhang D
    Cost Eff Resour Alloc; 2023 Jun; 21(1):37. PubMed ID: 37277820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Willingness to pay: a valid and reliable measure of health state preference?
    O'Brien B; Viramontes JL
    Med Decis Making; 1994; 14(3):289-97. PubMed ID: 7934716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Willingness to Pay for a Quality-Adjusted Life Year among Gastrointestinal Cancer Patients at a Tertiary Hospital of Vietnam, 2022.
    Tran BT; Tran TT; La NQ; Nguyen TTP; Nguyen MH; Huynh TMC; Vu HP
    Asian Pac J Cancer Prev; 2024 May; 25(5):1725-1735. PubMed ID: 38809645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Examining Willingness-to-Pay and Zero Valuations for a Health Improvement with Logistic Regression.
    Mavrodi AG; Chatzopoulos SA; Aletras VH
    Inquiry; 2021; 58():469580211028102. PubMed ID: 34271848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A utility-theoretic model for QALYs and willingness to pay.
    Klose T
    Health Econ; 2003 Jan; 12(1):17-31. PubMed ID: 12483758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patients' willingness to pay for dental services in a population with limited restorative services.
    Nyamuryekung'e KK; Lahti SM; Tuominen RJ
    Community Dent Health; 2018 Aug; 35(3):167-172. PubMed ID: 30106521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Willingness-to-pay stated preferences for 8 health-related quality-of-life domains in psoriatic arthritis: a pilot study.
    Hu SW; Holt EW; Husni ME; Qureshi AA
    Semin Arthritis Rheum; 2010 Apr; 39(5):384-97. PubMed ID: 19095293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Willingness to pay for physician services at a primary contact in Ukraine: results of a contingent valuation study.
    Danyliv A; Pavlova M; Gryga I; Groot W
    BMC Health Serv Res; 2013 Jun; 13():208. PubMed ID: 23758839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Willingness to Pay for Health-Related Quality of Life Gains in Relation to Disease Severity and the Age of Patients.
    Reckers-Droog V; van Exel J; Brouwer W
    Value Health; 2021 Aug; 24(8):1182-1192. PubMed ID: 34372984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of Cost-Effectiveness Threshold for Health Care Interventions in Malaysia.
    Lim YW; Shafie AA; Chua GN; Ahmad Hassali MA
    Value Health; 2017 Sep; 20(8):1131-1138. PubMed ID: 28964445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality-adjusted life years was a poor predictor of women's willingness to pay in acute and chronic conditions: results of a survey.
    Franic DM; Pathak DS; Gafni A
    J Clin Epidemiol; 2005 Mar; 58(3):291-303. PubMed ID: 15718119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimating Willingness to Pay for an Improved Service Delivery to Patients Referring Namazi Hospital Chemical Therapy Ward in Iran Using Contingent Valuation.
    Kavosi Z; Jafari A; Keshtkaran V; Pourahmadi E
    Asian Pac J Cancer Prev; 2018 Jul; 19(7):1817-1823. PubMed ID: 30049193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Willingness to Pay for One Additional Quality Adjusted Life Year: A Population Based Survey from China.
    Ye Z; Abduhilil R; Huang J; Sun L
    Appl Health Econ Health Policy; 2022 Nov; 20(6):893-904. PubMed ID: 35934772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monetary Value of Quality-Adjusted Life Years (QALY) among Patients with Cardiovascular Disease: a Willingness to Pay Study (WTP).
    Moradi N; Rashidian A; Rasekh HR; Olyaeemanesh A; Foroughi M; Mohammadi T
    Iran J Pharm Res; 2017; 16(2):823-833. PubMed ID: 28979338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The value of a QALY towards the end of life and its determinants: Experimental evidence.
    Fischer B; Telser H; Zweifel P; von Wyl V; Beck K; Weber A
    Soc Sci Med; 2023 Jun; 326():115909. PubMed ID: 37121067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An exploratory study to estimate cost-effectiveness threshold value for life saving treatments in western Iran.
    Moradi N; Woldemichael A; Malekian P; Rotvandi DM; Rezaei S
    Cost Eff Resour Alloc; 2020; 18():47. PubMed ID: 33110399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perception of the economic value of primary care services: a Willingness to Pay study.
    Martín-Fernández J; Gómez-Gascón T; Oliva-Moreno J; del Cura-González MI; Domínguez-Bidagor J; Beamud-Lagos M; Sanz-Cuesta T
    Health Policy; 2010 Mar; 94(3):266-72. PubMed ID: 19945763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring the willingness to pay for a quality-adjusted life-year in the state of Penang, Malaysia.
    Shafie AA; Lim YW; Chua GN; Hassali MA
    Clinicoecon Outcomes Res; 2014; 6():473-81. PubMed ID: 25364267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Willingness-to-Accept and Willingness-to-Pay Ratios of Prevention of Mother-to-Child Transmission Services in a Nigerian Hospital: A Cross-Sectional Contingent Valuation Study.
    Isah A; Adibe MO; Anosike C; Aluh DO; Onyekwelu PO; Okonta MJ; Ukwe CV
    Value Health Reg Issues; 2019 Sep; 19():112-121. PubMed ID: 31404819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.